Name three different possibilities/opportunities for how to develop drugs against COVID-19 when taking into account the SARS-Cov2 reproduction cycle.
What makes the Main-Protease a good drug target against COVID-19?
How can the crystal structure of the SARS-Cov2 Main Protease inform drug development?
How can the crystal structure of the SARS-Cov2 RNA polymerase inform drug development?
How can the crystal structure of the SARS-Cov2 spike protein inform drug development
ow can the cryoEM structure of the spike protein in complex with ACE2 help to understand the effect/thread of SARS-Cov2 mutants (‘british’ variant, ‘indian’ variant)
Last changeda year ago